By the way, the function of platelets is to promote healing and aid in the clotting of blood at the site of a wound.
PRP had been used in medicine for the last two decades.
Platelets contain growth factors that promote regeneration of the cells in the body. Our blood also contains cells known as platelets, apart from redish blood cells and almost white blood cells. Treatment that results in additional collagen production could counteract the effects seen in aged and also sun damaged skin.
We anticipate the company’s current cash to finance operations well into 2018 and allow for serious partnering discussions to commence, as financing is no longer a poser, with a burn rate of approximately $ 180000 per month.
That said, this will limit degradation to the product upon application as well as removes the variability in injections. On p of that, lastly, a cooling device is incorporated at the injection site, that alleviates the need for anesthetic.
Transitioning to Late Stage Development CompanyRepliCel has recently announced positive results from the Phase 1 RCH study 01 and we anticipate additional preliminary results from the Phase 1 studies of ‘RCS01’ and RCT 01 to be announced shortly.
Juvederm, that is composed of hyaluronic acid, is an injectable facial filler and had sales of $ 264 million in 2015.
RepliCel anticipates the next major partnership announcement to be with a multinational corporation in regards to the RCI 02 injector. Fact, every unit consisted of one common share stock and one warrant to purchase one common share stock at a price of $ 85 per share. Accordingly the ‘RCI 02’ injector is designed to deliver programmable volumes of substance into specific cell layers of the skin with minimal pressure or shear stress. While representing a large opportunity for RepliCel with RCS RCI 02 for Dermal Injections RepliCel is developing a next generation dermal injector that can be used in conjunction with the company’s cell based therapeutics, as the population continues to age, demand for products that treat wrinkles and fine lines is only preparing to increase. Known we anticipate preliminary data from this trial by the end of the first quarter of The skin rejuvenation market is enormous. Please visit ourwebsitefor additional information on Zacks SCR and to view ourdisclaimer. In 2015, RepliCel received clearance from the German Competent Authority to initiate a Phase 1 clinical trial to test the safety and efficacy of ‘RCS 01’ in subjects with aged or damaged skin. Botox, that is used to treat facial wrinkles, had 2015 worldwide sales of $ 8 billion in 2015.